The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 51,183 | 1,152,520 | SH | SOLE | 1,152,520 | 0 | 0 | ||
AbbVie Inc. | Common | 00287Y109 | 10 | 156 | SH | SOLE | 156 | 0 | 0 | ||
Acadia Healthcare Company, Inc. | Common | 00404A109 | 10,080 | 231,200 | SH | SOLE | 231,200 | 0 | 0 | ||
Accelerate Diagnostics, Inc. | Common | 00430H102 | 2,420 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Acceleron Pharma, Inc. | Common | 00434H108 | 1,441 | 54,450 | SH | SOLE | 54,450 | 0 | 0 | ||
Adaptimmune Therapeutics plc | Sponsored ADR | 00653A107 | 8,080 | 1,466,368 | SH | SOLE | 1,466,368 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | Note 2.00% 8/15/19 | 00767EAB8 | 10,400 | 13,000,000 | PRN | SOLE | 13,000,000 | 0 | 0 | ||
Affimed N.V. | Common | N01045108 | 3,232 | 1,405,324 | SH | SOLE | 1,405,324 | 0 | 0 | ||
Akorn, Inc. | Common | 009728106 | 7,892 | 327,735 | SH | SOLE | 327,735 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 96,496 | 795,905 | SH | SOLE | 795,905 | 0 | 0 | ||
Allergan plc | Shares | G0177J108 | 74,211 | 310,610 | SH | SOLE | 310,610 | 0 | 0 | ||
Allergan plc | Preferred Convertible | G0177J116 | 4,249 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
Alliqua BioMedical, Inc. | Common | 019621200 | 833 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | ||
Allscripts Healthcare Solutions, Inc. | Common | 01988P108 | 600 | 47,300 | SH | SOLE | 47,300 | 0 | 0 | ||
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 12,505 | 243,995 | SH | SOLE | 243,995 | 0 | 0 | ||
AmerisourceBergen Corporation | Common | 03073E105 | 29,266 | 330,687 | SH | SOLE | 330,687 | 0 | 0 | ||
Amgen Inc. | Common | 031162100 | 112,359 | 684,824 | SH | SOLE | 684,824 | 0 | 0 | ||
Amicus Therapeutics, Inc. | Common | 03152W109 | 2,986 | 418,730 | SH | SOLE | 418,730 | 0 | 0 | ||
ARCA biopharma, Inc. | Common | 00211Y407 | 2,028 | 811,227 | SH | SOLE | 811,227 | 0 | 0 | ||
Ardelyx, Inc. | Common | 039697107 | 8,088 | 639,370 | SH | SOLE | 639,370 | 0 | 0 | ||
AstraZeneca PLC | Sponsored ADR | 046353108 | 14,443 | 463,800 | SH | SOLE | 463,800 | 0 | 0 | ||
Auris Medical Holding AG | Common | H03579101 | 712 | 774,504 | SH | SOLE | 774,504 | 0 | 0 | ||
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 6,043 | 624,288 | SH | SOLE | 624,288 | 0 | 0 | ||
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 3,205 | 87,531 | SH | SOLE | 87,531 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | Common | 079481107 | 740 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
Biogen Inc. | Common | 09062X103 | 132,602 | 484,974 | SH | SOLE | 484,974 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 44,403 | 505,845 | SH | SOLE | 505,845 | 0 | 0 | ||
bluebird bio, Inc. | Common | 09609G100 | 4,485 | 49,345 | SH | SOLE | 49,345 | 0 | 0 | ||
Bristol-Myers Squibb Co. | Common | 110122108 | 10,142 | 186,500 | SH | SOLE | 186,500 | 0 | 0 | ||
Cardinal Health, Inc. | Common | 14149Y108 | 6,247 | 76,600 | SH | SOLE | 76,600 | 0 | 0 | ||
Care Capital Properties, Inc. | Common | 141624106 | 9,271 | 345,022 | SH | SOLE | 345,022 | 0 | 0 | ||
Celgene Corporation | Common | 151020104 | 170,047 | 1,366,605 | SH | SOLE | 1,366,605 | 0 | 0 | ||
Celldex Therapeutics, Inc. | Common | 15117B103 | 382 | 105,800 | SH | SOLE | 105,800 | 0 | 0 | ||
Cellectis S.A. | Sponsored ADR | 15117K103 | 7,446 | 310,250 | SH | SOLE | 310,250 | 0 | 0 | ||
Centene Corporation | Common | 15135B101 | 10,283 | 144,300 | SH | SOLE | 144,300 | 0 | 0 | ||
Charles River Laboratories International, Inc. | Common | 159864107 | 11,433 | 127,100 | SH | SOLE | 127,100 | 0 | 0 | ||
Cidara Therapeutics, Inc. | Common | 171757107 | 2,234 | 286,472 | SH | SOLE | 286,472 | 0 | 0 | ||
Cigna Corporation | Common | 125509109 | 12,291 | 83,900 | SH | SOLE | 83,900 | 0 | 0 | ||
Coherus BioSciences, Inc. | Common | 19249H103 | 1,904 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
Community Health Systems, Inc. | Common | 203668108 | 1,809 | 203,935 | SH | SOLE | 203,935 | 0 | 0 | ||
CVS Health Corporation | Common | 126650100 | 32,333 | 411,891 | SH | SOLE | 411,891 | 0 | 0 | ||
CytomX Therapeutics, Inc. | Common | 23284F105 | 9,155 | 530,092 | SH | SOLE | 530,092 | 0 | 0 | ||
DBV Technologies S.A. | Common | 23306J101 | 2,310 | 65,600 | SH | SOLE | 65,600 | 0 | 0 | ||
Dermira, Inc. | Sponsored ADR | 24983L104 | 5,635 | 165,200 | SH | SOLE | 165,200 | 0 | 0 | ||
DexCom, Inc. | Common | 252131107 | 6,033 | 71,200 | SH | SOLE | 71,200 | 0 | 0 | ||
Diplomat Pharmacy, Inc. | Common | 25456K101 | 2,077 | 130,223 | SH | SOLE | 130,223 | 0 | 0 | ||
Dynavax Technologies Corporation | Common | 268158201 | 2,053 | 345,050 | SH | SOLE | 345,050 | 0 | 0 | ||
Edwards Lifesciences Corporation | Common | 28176E108 | 5,259 | 55,900 | SH | SOLE | 55,900 | 0 | 0 | ||
Egalet Corporation | Note 5.50% 4/1/20 | 28226BAB0 | 5,758 | 7,000,000 | PRN | SOLE | 7,000,000 | 0 | 0 | ||
Eli Lilly & Company | Common | 532457108 | 41,475 | 493,100 | SH | SOLE | 493,100 | 0 | 0 | ||
Endo International plc | Shares | G30401106 | 10,206 | 914,548 | SH | SOLE | 914,548 | 0 | 0 | ||
Epizyme, Inc. | Common | 29428V104 | 6,208 | 362,000 | SH | SOLE | 362,000 | 0 | 0 | ||
Exelixis, Inc. | Common | 30161Q104 | 11,954 | 551,647 | SH | SOLE | 551,647 | 0 | 0 | ||
Flex Pharma, Inc. | Common | 33938A105 | 713 | 162,124 | SH | SOLE | 162,124 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd. | Shares | M46135105 | 4,605 | 930,398 | SH | SOLE | 930,398 | 0 | 0 | ||
Forward Pharma A/S | Sponsored ADR | 34986J105 | 2,642 | 122,835 | SH | SOLE | 122,835 | 0 | 0 | ||
Galapagos NV | Sponsored ADR | 36315X101 | 9,975 | 115,738 | SH | SOLE | 115,738 | 0 | 0 | ||
GenMark Diagnostics, Inc. | Common | 372309104 | 1,197 | 93,349 | SH | SOLE | 93,349 | 0 | 0 | ||
Gilead Sciences, Inc. | Common | 375558103 | 171,846 | 2,530,131 | SH | SOLE | 2,530,131 | 0 | 0 | ||
GlaxoSmithKline plc | Sponsored ADR | 37733W105 | 15,135 | 359,000 | SH | SOLE | 359,000 | 0 | 0 | ||
Global Blood Therapeutics, Inc. | Common | 37890U108 | 6,357 | 172,500 | SH | SOLE | 172,500 | 0 | 0 | ||
Global Medical REIT Inc. | Common | 37954A204 | 666 | 73,400 | SH | SOLE | 73,400 | 0 | 0 | ||
Grifols, S.A. | Sponsored ADR | 398438408 | 3,133 | 166,000 | SH | SOLE | 166,000 | 0 | 0 | ||
Halozyme Therapeutics, Inc. | Common | 40637H109 | 2,592 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
HCA Holdings, Inc. | Common | 40412C101 | 5,645 | 63,432 | SH | SOLE | 63,432 | 0 | 0 | ||
HCP, Inc. | Common | 40414L109 | 1,423 | 45,500 | SH | SOLE | 45,500 | 0 | 0 | ||
Health Care Select Sector SPDR Fund | SBI Healthcare | 81369Y209 | 10,455 | 140,600 | SH | SOLE | 140,600 | 0 | 0 | ||
Healthcare Realty Trust, Inc. | Common | 421946104 | 2,210 | 68,000 | SH | SOLE | 68,000 | 0 | 0 | ||
Healthcare Trust of America, Inc. | Class A | 42225P501 | 1,447 | 46,000 | SH | SOLE | 46,000 | 0 | 0 | ||
Horizon Pharma plc | Shares | G4617B105 | 2,408 | 162,900 | SH | SOLE | 162,900 | 0 | 0 | ||
Humana Inc. | Common | 444859102 | 31,704 | 153,800 | SH | SOLE | 153,800 | 0 | 0 | ||
IDEXX Laboratories, Inc. | Common | 45168D104 | 20,463 | 132,352 | SH | SOLE | 132,352 | 0 | 0 | ||
Illumina, Inc. | Common | 452327109 | 50,742 | 297,360 | SH | SOLE | 297,360 | 0 | 0 | ||
Impax Laboratories, Inc. | Common | 45256B101 | 1,573 | 124,335 | SH | SOLE | 124,335 | 0 | 0 | ||
Incyte Corporation | Common | 45337C102 | 92,670 | 693,275 | SH | SOLE | 693,275 | 0 | 0 | ||
Innoviva, Inc. | Common | 45781M101 | 3,441 | 248,803 | SH | SOLE | 248,803 | 0 | 0 | ||
Intellia Therapeutics, Inc. | Common | 45826J105 | 1,012 | 71,842 | SH | SOLE | 71,842 | 0 | 0 | ||
iShares Nasdaq Biotechnology ETF | Nasdaq Biotech ETF | 464287556 | 22,866 | 77,970 | SH | SOLE | 77,970 | 0 | 0 | ||
Jazz Pharmaceuticals plc | Shares | G50871105 | 48,098 | 331,411 | SH | SOLE | 331,411 | 0 | 0 | ||
Johnson & Johnson | Common | 478160104 | 88,974 | 714,362 | SH | SOLE | 714,362 | 0 | 0 | ||
Juno Therapeutics, Inc. | Common | 48205A109 | 1,263 | 56,900 | SH | SOLE | 56,900 | 0 | 0 | ||
Karyopharm Therapeutics Inc. | Common | 48576U106 | 7,771 | 605,224 | SH | SOLE | 605,224 | 0 | 0 | ||
LTC Properties, Inc. | Common | 502175102 | 6,525 | 136,212 | SH | SOLE | 136,212 | 0 | 0 | ||
Mallinckrodt plc | Shares | G5785G107 | 2,759 | 61,900 | SH | SOLE | 61,900 | 0 | 0 | ||
McKesson Corporation | Common | 58155Q103 | 16,768 | 113,100 | SH | SOLE | 113,100 | 0 | 0 | ||
Medical Properties Trust, Inc. | Common | 58463J304 | 12,989 | 1,007,717 | SH | SOLE | 1,007,717 | 0 | 0 | ||
Medtronic plc | Shares | G5960L103 | 49,386 | 613,030 | SH | SOLE | 613,030 | 0 | 0 | ||
Merck & Co., Inc. | Common | 58933Y105 | 76,143 | 1,198,349 | SH | SOLE | 1,198,349 | 0 | 0 | ||
Merus B.V. | Common | N5749R100 | 11,682 | 479,150 | SH | SOLE | 479,150 | 0 | 0 | ||
Molina Healthcare, Inc. | Common | 60855R100 | 18,356 | 402,541 | SH | SOLE | 402,541 | 0 | 0 | ||
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 6,734 | 504,400 | SH | SOLE | 504,400 | 0 | 0 | ||
Mylan N.V. | Shares | N59465109 | 60,451 | 1,550,412 | SH | SOLE | 1,550,412 | 0 | 0 | ||
Myovant Sciences Ltd. | Common | G637AM102 | 4,696 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Nabriva Therapeutics AG | Sponsored ADR | 62957M104 | 2,798 | 233,334 | SH | SOLE | 233,334 | 0 | 0 | ||
NanoString Technologies, Inc. | Common | 63009R109 | 2,255 | 113,500 | SH | SOLE | 113,500 | 0 | 0 | ||
Natera, Inc. | Common | 632307104 | 7,827 | 882,358 | SH | SOLE | 882,358 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | Common | 64125C109 | 19,315 | 446,074 | SH | SOLE | 446,074 | 0 | 0 | ||
New Senior Investment Group Inc. | Common | 648691103 | 5,794 | 567,997 | SH | SOLE | 567,997 | 0 | 0 | ||
Novartis AG | Sponsored ADR | 66987V109 | 18,478 | 248,800 | SH | SOLE | 248,800 | 0 | 0 | ||
Novavax, Inc. | Common | 670002104 | 731 | 571,000 | SH | SOLE | 571,000 | 0 | 0 | ||
Novo Nordisk A/S | Sponsored ADR | 670100205 | 2,845 | 83,000 | SH | SOLE | 83,000 | 0 | 0 | ||
Omega Healthcare Investors, Inc. | Common | 681936100 | 15,130 | 458,616 | SH | SOLE | 458,616 | 0 | 0 | ||
Paratek Pharmaceuticals, Inc. | Common | 699374302 | 14,680 | 762,581 | SH | SOLE | 762,581 | 0 | 0 | ||
Perrigo Company plc | Shares | G97822103 | 2,476 | 37,300 | SH | SOLE | 37,300 | 0 | 0 | ||
Pfizer Inc. | Common | 717081103 | 39,228 | 1,146,689 | SH | SOLE | 1,146,689 | 0 | 0 | ||
Physicians Realty Trust | Common | 71943U104 | 10,544 | 530,672 | SH | SOLE | 530,672 | 0 | 0 | ||
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 10,244 | 3,940,084 | SH | SOLE | 3,940,084 | 0 | 0 | ||
PRA Health Sciences, Inc. | Common | 69354M108 | 6,653 | 102,000 | SH | SOLE | 102,000 | 0 | 0 | ||
Puma Biotechnology, Inc. | Common | 74587V107 | 9,679 | 260,200 | SH | SOLE | 260,200 | 0 | 0 | ||
Quorum Health Corporation | Common | 74909E106 | 129 | 23,725 | SH | SOLE | 23,725 | 0 | 0 | ||
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 72,722 | 187,666 | SH | SOLE | 187,666 | 0 | 0 | ||
Retrophin, Inc. | Common | 761299106 | 3,100 | 167,949 | SH | SOLE | 167,949 | 0 | 0 | ||
The RMR Group Inc. | Class A | 74967R106 | 368 | 7,441 | SH | SOLE | 7,441 | 0 | 0 | ||
Sabra Health Care REIT, Inc. | Common | 78573L106 | 15,389 | 550,990 | SH | SOLE | 550,990 | 0 | 0 | ||
Sage Therapeutics, Inc. | Common | 78667J108 | 6,430 | 90,480 | SH | SOLE | 90,480 | 0 | 0 | ||
Sanofi | Sponsored ADR | 80105N105 | 13,801 | 305,000 | SH | SOLE | 305,000 | 0 | 0 | ||
Sarepta Therapeutics, Inc. | Common | 803607100 | 15,143 | 511,600 | SH | SOLE | 511,600 | 0 | 0 | ||
Senior Housing Properties Trust | Shares | 81721M109 | 13,093 | 646,554 | SH | SOLE | 646,554 | 0 | 0 | ||
Shire plc | Sponsored ADR | 82481R106 | 40,319 | 231,413 | SH | SOLE | 231,413 | 0 | 0 | ||
Spark Therapeutics, Inc. | Common | 84652J103 | 1,296 | 24,300 | SH | SOLE | 24,300 | 0 | 0 | ||
SPDR S&P Biotech ETF | S&P Biotech ETF | 78464A870 | 15,703 | 226,460 | SH | SOLE | 226,460 | 0 | 0 | ||
Tenet Healthcare Corporation | Common | 88033G407 | 2,913 | 164,500 | SH | SOLE | 164,500 | 0 | 0 | ||
Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | 9,230 | 1,004,322 | SH | SOLE | 1,004,322 | 0 | 0 | ||
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 32,596 | 1,015,758 | SH | SOLE | 1,015,758 | 0 | 0 | ||
Thermo Fisher Scientific Inc. | Common | 883556102 | 35,024 | 228,020 | SH | SOLE | 228,020 | 0 | 0 | ||
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 5,992 | 88,400 | SH | SOLE | 88,400 | 0 | 0 | ||
uniQure N.V. | Shares | N90064101 | 1,393 | 241,021 | SH | SOLE | 241,021 | 0 | 0 | ||
United Therapeutics Corporation | Common | 91307C102 | 5,951 | 43,961 | SH | SOLE | 43,961 | 0 | 0 | ||
UnitedHealth Group Inc. | Common | 91324P102 | 50,327 | 306,852 | SH | SOLE | 306,852 | 0 | 0 | ||
Universal Health Services, Inc. | Class B | 913903100 | 5,996 | 48,180 | SH | SOLE | 48,180 | 0 | 0 | ||
Valeant Pharmaceuticals International, Inc. | Common | 91911K102 | 2,118 | 192,000 | SH | SOLE | 192,000 | 0 | 0 | ||
Ventas, Inc. | Common | 92276F100 | 11,446 | 175,991 | SH | SOLE | 175,991 | 0 | 0 | ||
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 113,014 | 1,033,503 | SH | SOLE | 1,033,503 | 0 | 0 | ||
Welltower Inc. | Common | 95040Q203 | 12,624 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Welltower Inc. | 6.50% Preferred Perpetual | 95040Q104 | 1,516 | 21,400 | SH | SOLE | 21,400 | 0 | 0 | ||
Xencor, Inc. | Common | 98401F105 | 478 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
Xenon Pharmaceuticals Inc. | Common | 98420N105 | 1,400 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
Zafgen, Inc. | Common | 98885E103 | 62 | 13,307 | SH | SOLE | 13,307 | 0 | 0 | ||
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 12,492 | 102,300 | SH | SOLE | 102,300 | 0 | 0 |